Monash Immunology and Stem Cell Laboratories (MISCL), Monash University, Melbourne, Victoria, Australia.
Nephrology (Carlton). 2012 Jan;17(1):1-10. doi: 10.1111/j.1440-1797.2011.01501.x.
Mesenchymal stem cells are a heterogeneous population of fibroblast-like stromal cells that have been isolated from the bone marrow and a number of organs and tissues including the kidney. They have multipotent and self-renewing properties and can differentiate into cells of the mesodermal lineage. Following their administration in vivo, mesenchymal stem cells migrate to damaged kidney tissue where they produce an array of anti-inflammatory cytokines and chemokines that can alter the course of injury. Mesenchymal stem cells are thought to elicit repair through paracrine and/or endocrine mechanisms that modulate the immune response resulting in tissue repair and cellular replacement. This review will discuss the features of mesenchymal stem cells and the factors they release that protect against kidney injury; the mechanisms of homing and engraftment to sites of inflammation; and further elucidate the immunomodulatory effect of mesenchymal stem cells and their ability to alter macrophage phenotype in a setting of kidney damage and repair.
间充质干细胞是一种异质性的成纤维样基质细胞群体,已从骨髓和许多器官和组织中分离出来,包括肾脏。它们具有多能性和自我更新的特性,并能分化为中胚层谱系的细胞。在体内给药后,间充质干细胞迁移到受损的肾脏组织,在那里产生一系列抗炎细胞因子和趋化因子,可改变损伤的进程。间充质干细胞被认为通过旁分泌和/或内分泌机制来引发修复,这些机制调节免疫反应,从而导致组织修复和细胞替代。本文综述将讨论间充质干细胞的特征及其释放的保护肾脏免受损伤的因子;归巢和植入炎症部位的机制;并进一步阐明间充质干细胞的免疫调节作用及其在肾脏损伤和修复中改变巨噬细胞表型的能力。